, Tracking Stock Market Picks
Enter Symbol:
Akzo Nobel N.V. (ADR) (AKZOY) [hlAlert]

down 16.01 %

Akzo Nobel N.V. (ADR) (AKZOY) rated Sell by Citigroup

Posted on: Monday,  Nov 26, 2012  8:25 AM ET by Citigroup

Citigroup rated Sell Akzo Nobel N.V. (ADR) (OTCBB: AKZOY) on 11/26/2012, when the stock price was $18.25. Since then, Akzo Nobel
N.V. (ADR) has gained 19.07% of its value until Citigroup rated AKZOY Neutral on 12/19/2012, when the price was $21.73.
If you would have followed this Citigroup's recommendation on AKZOY, you would have lost 16.01% of your investment in 23 days.

Akzo Nobel N.V. (AkzoNobel) is a global paints and coatings company and a producer of specialty chemicals. The Company operates in three segments: Decorative Paints, Performance Coatings and Specialty Chemicals. During the year ended December 31, 2009, the Company two distributors in Continental Europe. During 2009, it also acquired SABA, Kronospan and Dow Powder Coatings assets. During 2009, it also divested Chemcraft Brazil and the non-stick businesses. In January 2009, the Company completed the acquisition of LII Europe.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2014 8:25 AM Buy
as of 12/31/2012
1 Week   
1 Month down  -13.88 %
3 Months down  -19.06 %
1 YTD down  -19.06 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/19/2012 8:25 AM Hold
11/26/2012 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy